RAD51 and ovarian cancer: In addition, CDCA8 silencing sensitizes ovarian cancer cells to olaparib and cisplatin via induction of the G2/M phase arrest, acceleration of cell apoptosis, enhancement of DNA damage, and interference with RAD51 accumulation in vitro.12